Physician profile
Derek Chung
NPI 1588747935
$4,210.86
in general payments reported to CMS, 2019-2025
25 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,230 · 2020: $680 · 2021: $355 · 2022: $546 · 2023: $576 · 2024: $344 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,400.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $993.46 | 2019-2025 | |
| Lilly USA, LLC | $712.92 | 2019-2024 | Mounjaro |
| Janssen Pharmaceuticals, INC | $670.09 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $271.88 | 2021-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $210.96 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $203.82 | 2019-2023 | Verquvo, Steglatro |
| Exact Sciences Corporation | $130.71 | 2024-2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $125.00 | 2019 | |
| Amgen INC. | $113.36 | 2025 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $96.05 | 2019-2021 | |
| Global Blood Therapeutics, INC. | $75.27 | 2021 | |
| Sanofi-Aventis U.S. LLC | $70.86 | 2019-2020 | |
| Abbvie INC. | $69.08 | 2024-2025 | |
| Pfizer INC. | $68.30 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.86 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $61.43 | 2025 | Dovato, Apretude |
| Bioventus LLC | $53.76 | 2025 | Exogen Ultrasound Bone Healing System |
| Arbor Pharmaceuticals, INC. | $37.08 | 2019 | |
| Medtronic, INC. | $35.01 | 2025 | Minimed 780g |
| Currax Pharmaceuticals LLC | $34.02 | 2020 | |
| Gilead Sciences, INC. | $30.84 | 2021-2025 | Biktarvy |
| Tactile Systems Technology INC | $25.46 | 2025 | Nimbl, Flexitouch Plus |
| Nalpropion Pharmaceuticals LLC | $19.70 | 2019 | |
| Steris Corporation | $18.61 | 2020 | |
| Dentsply Sirona INC | $16.33 | 2024 | Q-Mix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.